<?xml version="1.0" encoding="UTF-8"?>
<p>Cirsimaritin is a flavonoid with diversified pharmacological activities including antioxidant, anti-inflammatory, antimicrobial, anticancer, and enzyme inhibitory activities. This bioactive compound belongs to a class known as 7-O-methylated flavonoid [
 <xref rid="B36-molecules-25-04435" ref-type="bibr">36</xref>]. Its anticancer activities have been explored using different cancer cell lines, such as breast, lung, and gallbladder [
 <xref rid="B37-molecules-25-04435" ref-type="bibr">37</xref>]. This anticancer compound plays a vital role in angiogenesis inhibition through the downregulation of p-Akt, p-ERK, and VEGF in MDA-MB-231 breast cancer cells [
 <xref rid="B38-molecules-25-04435" ref-type="bibr">38</xref>]. In human gallbladder carcinoma GBC-SD cells, cirsimaritin inhibits the growth of cancerous cells through mitochondrial apoptosis. Cirsimaritin triggers endoplasmic reticulum stress by forming ROS, and it downregulates the phosphorylation of Akt [
 <xref rid="B39-molecules-25-04435" ref-type="bibr">39</xref>].
</p>
